🇺🇸 FDA
Patent

US 6565831

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

expired A61KA61K35/765A61K38/13

Quick answer

US patent 6565831 (Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K35/765, A61K38/13, A61P, A61P1/00